Engineered adult stem cells: a promising tool for anti-cancer therapy

키워드

참고문헌 (79)

1. Sung H, "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
2. Nurgali K, "Editorial : adverse effects of cancer chemotherapy : anything new to improve tolerance and reduce sequelae?", Front Pharmacol, 9, pp.245~ (2018)
3. Kayiran O, "Lymphedema : from diagnosis to treatment", Turk J Surg, 33, pp.51~57 (2017)
4. Harrold J, "Quantification of radiation injury on neutropenia and the link between absolute neutrophil count time course and overall survival in nonhuman primates treated with G-CSF", Pharm Res, 37, pp.102~ (2020)
5. Gurusamy N, "Adult stem cells for regenerative therapy", Prog Mol Biol Transl Sci, 160, pp.1~22 (2018)
6. Gage FH, "Mammalian neural stem cells", Science, 287, pp.1433~1438 (2000)
7. Aboody KS, "Neural stem cells display extensive tropism for pathology in adult brain : evidence from intracranial gliomas", Proc Natl Acad Sci U S A, 97, pp.12846~12851 (2000)
8. Erlandsson A, "Stem cell factor is a chemoattractant and a survival factor for CNS stem cells", Exp Cell Res, 301, pp.201~210 (2004)
9. Widera D, "MCP-1induces migration of adult neural stem cells", Eur J Cell Biol, 83, pp.381~387 (2004)
10. Imitola J, "Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha", CXC chemokine receptor 4 pathway, 2004, pp.101, 18117~18122
11. Sun L, "Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury", J Clin Invest, 113, pp.1364~1374 (2004)
12. Loebinger MR, "Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer", Cancer Res, 69, pp.4134~4142 (2009)
13. Kidd S, "Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging", Stem Cells, 27, pp.2614~2623 (2009)
14. Frank RT, "Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies", PLoS One, 4, pp.e8314~ (2009)
15. Rachakatla RS, "Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs", Cancer Invest, 26, pp.662~670 (2008)
16. Joo KM, "Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases", Mol Ther, 17, pp.570~575 (2009)
17. Dachs GU, "From bench to bedside for gene-directed enzyme prodrug therapy of cancer", Anticancer Drugs, 16, pp.349~359 (2005)
18. Longley DB, "5-fluorouracil : mechanisms of action and clinical strategies", Nat Rev Cancer, 3, pp.330~338 (2003)
19. Kilstrup M, "Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli", J Bacteriol, 171, pp.2124~2127 (1989)
20. Kucerova L, "Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy", Cancer Res, 67, pp.6304~6313 (2007)
21. Gutova M, "Quantitative evaluation of intraventricular delivery of therapeutic neural stem cells to orthotopic glioma", Front Oncol, 9, pp.68~ (2019)
22. Najbauer J, "Cellular host responses to gliomas", PLoS One, 7, pp.e35150~ (2012)
23. Ao Q, "Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries", Med Hypotheses, 69, pp.1234~1237 (2007)
24. Ko TP, "Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution", J Biol Chem, 278, pp.19111~19117 (2003)
25. Nouri FS, "Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme", prodrug systems, 2015, pp.200, 179~187
26. Ho YK, "A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy", Sci Rep, 10, pp.14257~ (2020)
27. Amara I, "Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors", Biochimie, 105, pp.4~11 (2014)
28. Portnow J, "Neural stem cell-based anticancer gene therapy : a first-in-human study in recurrent high-grade glioma patients", Clin Cancer Res, 23, pp.2951~2960 (2017)
29. Wierdl M, "Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase", Cancer Res, 61, pp.5078~5082 (2001)
30. Danks MK, "Enzyme-prodrug systems : carboxylesterase", CPT-11, 2004, pp.90, 247~262
31. Bachoud-Levi AC, "Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation", Lancet, 356, pp.1975~1979 (2000)
32. DuBois SG, "Phase i study of the aurora a kinase inhibitor alisertib in combination with irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma : a nant(new approaches to neuroblastoma therapy)trial", J Clin Oncol, 34, pp.1368~1375 (2016)
33. Wierdl M, "An improved human carboxylesterase for enzyme", prodrug therapy with CPT-11, 2008, pp.15, 183~192
34. Metz MZ, "Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma : implications for clinical use", Stem Cells Transl Med, 2, pp.983~992 (2013)
35. Miller WH, "Phosphorylation of acyclovir(acycloguanosine)monophosphate by GMP kinase", J Biol Chem, 255, pp.7204~7207 (1980)
36. Bhaumik S, "Advances in imaging gene-directed enzyme prodrug therapy", Curr Pharm Biotechnol, 12, pp.497~507 (2011)
37. Wang C, "Neural stem cell-based dual suicide gene delivery for metastatic brain tumors", Cancer Gene Ther, 19, pp.796~801 (2012)
38. Davola ME, "Oncolytic viruses : how"lytic"must they be for therapeutic efficacy?", Oncoimmunology, 8, pp.e1581528~ (2019)
39. Lemos de Matos A, "Oncolytic viruses and the immune system : the dynamic duo", Mol Ther Methods Clin Dev, 17, pp.349~358 (2020)
40. Sage EK, "Genetically modified mesenchymal stromal cells in cancer therapy", Cytotherapy, 18, pp.1435~1445 (2016)
41. Ebrahimi S, "Interferonmediated tumor resistance to oncolytic virotherapy", J Cell Biochem, 118, pp.1994~1999 (2017)
42. Salmasi Z, "Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo", Biotechnol Prog, 36, pp.e3025~ (2020)
43. Gao F, "Mesenchymal stem cells and immunomodulation : current status and future prospects", Cell Death Dis, 7, pp.e2062~ (2016)
44. Wang X, "Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy", Oncol Lett, 21, pp.238~ (2021)
45. Yoon AR, "Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma", Cancer Res, 79, pp.4503~4514 (2019)
46. Hammad M, "Neural stem cells improve the delivery of oncolytic chimeric orthopoxvirus in a metastatic ovarian cancer model", Mol Ther Oncolytics, 18, pp.326~334 (2020)
47. Morshed RA, "Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction", Cancer Gene Ther, 22, pp.55~61 (2015)
48. Yanez-Mo M, "Biological properties of extracellular vesicles and their physiological functions", J Extracell Vesicles, 4, pp.27066~ (2015)
49. Kalluri R, "The biology, function, and biomedical applications of exosomes", Science, 367, pp.eaau6977~ (2020)
50. Ha D, "Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes : current perspectives and future challenges", Acta Pharm Sin B, 6, pp.287~296 (2016)
51. Alvarez-Erviti L, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes", Nat Biotechnol, 29, pp.341~345 (2011)
52. Hong D, "AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3with early evidence of clinical activity in lymphoma and lung cancer", Sci Transl Med, 7, pp.314~ (2015)
53. Huynh J, "Therapeutically exploiting STAT3 activity in cancer-using tissue repair as a road map", Nat Rev Cancer, 19, pp.82~96 (2019)
54. Moreira D, "STAT3inhibition combined with CpG immunostimulation activates antitumor immunity to eradicate genetically distinct castration-resistant prostate cancers", Clin Cancer Res, 24, pp.5948~5962 (2018)
55. Altanerova U, "Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes", Int J Cancer, 144, pp.897~908 (2019)
56. Yuan L, "Exosomes derived from MicroRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression", Front Oncol, 9, pp.1076~ (2019)
57. Berraondo P, "Cytokines in clinical cancer immunotherapy", Br J Cancer, 120, pp.6~15 (2019)
58. Palmer PA, "Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma", Eur J Cancer, 28A, pp.1038~1044 (1992)
59. Studeny M, "Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors", Cancer Res, 62, pp.3603~3608 (2002)
60. Chulpanova DS, "Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy", Front Cell Dev Biol, 8, pp.402~ (2020)
61. Chen X, "A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs", Mol Ther, 16, pp.749~756 (2008)
62. Pan G, "The receptor for the cytotoxic ligand TRAIL", Science, 276, pp.111~113 (1997)
63. Gao Z, "Mesenchymal stem cells : a potential targeted-delivery vehicle for anticancer drug, loaded nanoparticles", Nanomedicine, 9, pp.174~184 (2013)
64. Park JS, "Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells", Biomaterials, 31, pp.124~132 (2010)
65. von Maltzahn G, "Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas", Cancer Res, 69, pp.3892~3900 (2009)
66. Hirsch LR, "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance", Proc Natl Acad Sci U S A, 100, pp.13549~13554 (2003)
67. Mooney R, "Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy", ACS Nano, 8, pp.12450~12460 (2014)
68. Li Z, "Mesoporous silica nanoparticles with pHsensitive nanovalves for delivery of moxifloxacin provide improved treatment of lethal pneumonic tularemia", ACS Nano, 9, pp.10778~10789 (2015)
69. Guisasola E, "Magneticresponsive release controlled by hot spot effect", Langmuir, 31, pp.12777~12782 (2015)
70. Paris JL, "Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy", Nanoscale, 9, pp.5528~5537 (2017)
71. Hong M, "Engineering CAR-T cells for next-generation cancer therapy", Cancer Cell, 38, pp.473~488 (2020)
72. Liu X, "CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells", Cell Res, 27, pp.154~157 (2017)
73. Gschweng E, "Hematopoietic stem cells for cancer immunotherapy", Immunol Rev, 257, pp.237~249 (2014)
74. Giannoni F, "Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem", progenitor cells, 2013, pp.21, 1044~1054
75. Tumeh PC, "PD-1blockade induces responses by inhibiting adaptive immune resistance", Nature, 515, pp.568~571 (2014)
76. Hu Q, "Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy", Nat Biomed Eng, 2, pp.831~840 (2018)
77. Liu X, "Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model", Oncol Lett, 15, pp.6265~6274 (2018)
78. Lagasse E, "Purified hematopoietic stem cells can differentiate into hepatocytes in vivo", Nat Med, 6, pp.1229~1234 (2000)
79. Dachs GU, "Bystander or no bystander for gene directed enzyme prodrug therapy", Molecules, 14, pp.4517~4545 (2009)

관련 논문AI추천